LAWMAKERS PRAISE, CRITICIZE TRUMP PLAN ON DRUG PRICES
On Capitol Hill, reaction to President Donald Trump’s “American Patients First” plan to bring down prescription drug prices fell predictably along partisan lines: Republicans generally praised it, while Democrats criticized it for not going nearly far enough.
Republicans weren’t effusive in their support, but House Ways and Means Committee Chairman Kevin Brady, R-Texas, praised Trump for “leading the charge” to lower drug prices. House Energy and Commerce Committee Chairman Greg Walden, R-Ore., “applauded” Trump for “working to lower the cost of important medications.”
After Trump backed away from proposing that Medicare negotiate prices with drug companies – something he campaigned on in 2016 – Democrats sharply criticized the president. “I think very expensive champagne will be popping in drug company boardrooms across the country tonight,” said Rep. Elijah Cummings, the top Democrat on the House Oversight and Government Reform Committee.